Xueyan Zhen

887 total citations · 3 hit papers
21 papers, 615 citations indexed

About

Xueyan Zhen is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Xueyan Zhen has authored 21 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Biomedical Engineering and 6 papers in Biomaterials. Recurrent topics in Xueyan Zhen's work include RNA Interference and Gene Delivery (9 papers), Nanoplatforms for cancer theranostics (9 papers) and Nanoparticle-Based Drug Delivery (6 papers). Xueyan Zhen is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Nanoplatforms for cancer theranostics (9 papers) and Nanoparticle-Based Drug Delivery (6 papers). Xueyan Zhen collaborates with scholars based in China, United States and Australia. Xueyan Zhen's co-authors include Xiaoyu Xie, Sicen Wang, Wei Tao, Yongjiang Li, Na Kong, Yusi Bu, Wei Chen, Qi Hu, Seyoung Koo and Shuying Chen and has published in prestigious journals such as Chemical Reviews, Advanced Materials and Nature Communications.

In The Last Decade

Xueyan Zhen

21 papers receiving 610 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity

2023 146 citations Yongjiang Li, Wei Chen et al. Nature Communications profile →
Chemically Modified Platforms for Better RNA Therapeutics

2024 73 citations Yesi Shi, Xueyan Zhen et al. Chemical Reviews profile →
Clinical advances of mRNA vaccines for cancer immunotherapy

2025 32 citations Alexey V. Yaremenko, Muhammad Muzamil Khan et al. Med profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xueyan Zhen China	12	298	247	109	103	94	21	615
Hanchun Yao China	16	355 1.2×	183 0.7×	162 1.5×	245 2.4×	50 0.5×	44	678
Zikuan Gu China	9	178 0.6×	164 0.7×	63 0.6×	83 0.8×	197 2.1×	14	426
María del Pilar Chantada‐Vázquez Spain	15	161 0.5×	248 1.0×	99 0.9×	136 1.3×	139 1.5×	34	662
Yueru Dong China	7	203 0.7×	197 0.8×	57 0.5×	89 0.9×	204 2.2×	8	446
Junqiu Zhai China	14	163 0.5×	233 0.9×	78 0.7×	83 0.8×	77 0.8×	31	505
Shu‐Jin Li China	13	316 1.1×	290 1.2×	110 1.0×	121 1.2×	27 0.3×	22	742
Shili Yan China	17	254 0.9×	285 1.2×	155 1.4×	206 2.0×	39 0.4×	37	855
Yingying Geng United States	13	271 0.9×	359 1.5×	35 0.3×	132 1.3×	37 0.4×	23	658
Mohammad Ramezani Iran	10	141 0.5×	189 0.8×	147 1.3×	89 0.9×	37 0.4×	15	379

Countries citing papers authored by Xueyan Zhen

Since Specialization

Citations

This map shows the geographic impact of Xueyan Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueyan Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueyan Zhen more than expected).

Fields of papers citing papers by Xueyan Zhen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueyan Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueyan Zhen. The network helps show where Xueyan Zhen may publish in the future.

Co-authorship network of co-authors of Xueyan Zhen

This figure shows the co-authorship network connecting the top 25 collaborators of Xueyan Zhen. A scholar is included among the top collaborators of Xueyan Zhen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueyan Zhen. Xueyan Zhen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhen, Xueyan, Wei Chen, & Wei Tao. (2025). mRNA-based technology for engineered regenerative medicine. 2(1). 100185–100185. 1 indexed citations

LIU, Chuang, Xiangang Huang, Kok‐Siong Chen, et al.. (2025). Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles. Nature Nanotechnology. 20(10). 1526–1538. 7 indexed citations

Liu, Chang, Liping Zhang, Yi Wang, et al.. (2025). Preparation of Hybrid Molecularly Imprinted Polymers Based on 3‐Triethoxysilylpropyl Methacrylic Amide for Solid‐Phase Extraction of Gatifloxacin From Lake Water. Journal of Separation Science. 48(3). e70122–e70122. 1 indexed citations

Yaremenko, Alexey V., Muhammad Muzamil Khan, Xueyan Zhen, Yan Tang, & Wei Tao. (2025). Clinical advances of mRNA vaccines for cancer immunotherapy. Med. 6(1). 100562–100562. 32 indexed citations breakdown →

Wang, Shihua, et al.. (2025). Targeted and intelligent nano-drug delivery systems for colorectal cancer treatment. Frontiers in Bioengineering and Biotechnology. 13. 1582659–1582659. 5 indexed citations

Gao, Bowen, et al.. (2024). Leveraging plant-derived nanovesicles for advanced nucleic acid-based gene therapy. Theranostics. 15(1). 324–339. 10 indexed citations

Zhen, Xueyan, Yongjiang Li, Tingting Zhang, et al.. (2024). Biointerface‐Engineered Hybrid Nanovesicles for Targeted Reprogramming of Tumor Microenvironment. Advanced Materials. 36(41). e2401495–e2401495. 40 indexed citations

Shi, Yesi, Xueyan Zhen, Yiming Zhang, et al.. (2024). Correction to Chemically Modified Platforms for Better RNA Therapeutics. Chemical Reviews. 124(10). 6690–6692. 4 indexed citations

Shi, Yesi, Xueyan Zhen, Yiming Zhang, et al.. (2024). Chemically Modified Platforms for Better RNA Therapeutics. Chemical Reviews. 124(3). 929–1033. 73 indexed citations breakdown →

10.

Zhen, Xueyan, Lanlan Jia, Qingyu Tang, et al.. (2023). Hybrid biointerface engineering nanoplatform for dual-targeted tumor hypoxia relief and enhanced photodynamic therapy. Journal of Colloid and Interface Science. 647. 211–223. 6 indexed citations

11.

Li, Yongjiang, Wei Chen, Yong Kang, et al.. (2023). Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity. Nature Communications. 14(1). 6973–6973. 146 indexed citations breakdown →

12.

Saiding, Qimanguli, Zhongyang Zhang, Shuying Chen, et al.. (2023). Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery. Advanced Drug Delivery Reviews. 203. 115116–115116. 32 indexed citations

13.

Jia, Lanlan, Xueyan Zhen, Liang Chen, et al.. (2022). Bioinspired nano-plate-coral platform enabled efficient detection of circulating tumor cells via the synergistic capture of multivalent aptamer and tumor cell membrane. Journal of Colloid and Interface Science. 631(Pt B). 55–65. 17 indexed citations

14.

Xie, Xiaoyu, et al.. (2022). Rational construction of fluorescent molecular imprinted polymers for highly efficient glycoprotein detection. Analytica Chimica Acta. 1209. 339875–339875. 25 indexed citations

15.

Zhen, Xueyan, et al.. (2022). Biointerface engineering of self-protective bionic nanomissiles for targeted synergistic chemotherapy. Chinese Chemical Letters. 34(4). 107680–107680. 8 indexed citations

16.

Zhang, Xiaolin, et al.. (2022). Precise assembly of inside-out cell membrane camouflaged nanoparticles via bioorthogonal reactions for improving drug leads capturing. Acta Pharmaceutica Sinica B. 13(2). 852–862. 21 indexed citations

17.

Zhen, Xueyan, Huai‐Song Wang, Linhao Li, et al.. (2021). Surface functionalized biomimetic bioreactors enable the targeted starvation-chemotherapy to glioma. Journal of Colloid and Interface Science. 609. 307–319. 41 indexed citations

18.

Hu, Qi, Xiaolin Zhang, Lanlan Jia, et al.. (2020). Engineering biomimetic graphene nanodecoys camouflaged with the EGFR/HEK293 cell membrane for targeted capture of drug leads. Biomaterials Science. 8(20). 5690–5697. 14 indexed citations

19.

Xie, Xiaoyu, et al.. (2019). Facile preparation of photonic and magnetic dual responsive protein imprinted nanomaterial for specific recognition of bovine hemoglobin. Chemical Engineering Journal. 371. 130–137. 82 indexed citations

20.

Liang, Juan, Xueyan Zhen, Jun Zhu, et al.. (2012). Neonatal infection-associated mortality in China, a population-based study, 2003–2008. The Journal of Maternal-Fetal & Neonatal Medicine. 25(12). 2750–2755. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact